News und Analysen
Amgen Aktie: Zahlreiche Erfolge erzielt!
Die Amgen-Aktie verzeichnet einen bemerkenswerten Start ins Jahr 2025, mit einem Kursanstieg von 8,57 Prozent im vergangenen Monat. Der Biotechnologie-Konzern, der aktuell eine Marktkapitalisierung
Abbott Laboratories Aktie: Solide Grunddaten
Der bekannte Gesundheitskonzern Abbott Laboratories verzeichnet aktuell Bewegung an der Börse. Louis H. Morrone, Executive Vice President des Unternehmens, trennte sich am 28. Januar von 2.644
AbbVie Investors Trigger Trend-Following Signal: Time to Load Up
AbbVie (NYSE: ABBV) is a high-quality, dividend-growing pharmaceutical company with a robust outlook for growth: now is a good time to load up on shares. Fears of Humira’s patent cliff are
3 Stocks to Gain From Trump’s Family Caregiver Tax Credits
President Trump has endorsed the passage of a tax credit for family caregivers. The tax credit would be given to caregivers who take care of a parent, family member, or a loved one. The AARP
Momentum Grows for These 3 Healthcare Stocks
Today’s stock market has brought about a set of distracting indicators and methods to analyze a potential trade—or investment—opportunity, some of which might be accurate in a completely binary
Abbott Laboratories Will Outperform Healthcare Stocks in 2025
The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter, Abbott
UnitedHealth Group Pulls Back Into Another Healthy Opportunity
UnitedHealth Group (NYSE: UNH) stock price is pulling back from highs set last year, presenting a healthy opportunity for investors. Although the outlook for revenue growth has dimmed, the
Vertex's Pain Drug: Big Pharma's Next Major Success?
Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing treatments for cystic fibrosis (CF). Vertex is strategically expanding into the
Can Integrated Healthcare Stocks Succeed in Public Markets?
America’s health insurance industry continues to face scrutiny after it was thrust into the headlines after the murder of UnitedHealth Group Inc. (NYSE: UNH) owned United Healthcare CEO Brian
3 Stocks With Strong Capital Returns and Insider Buying Signals
Capital returns are a driving force for markets and central to the stocks on this list. These stocks pay significant dividends, repurchase shares robustly, or both, and insider buying is strong
BioNTech gibt auf der 43. J.P. Morgan Healthcare-Konferenz Updates zur Geschäfts- und Pipeline-Entwicklung
- BioNTech fokussiert sich in der Umsetzung der Onkologie-Strategie auf tumorübergreifende (Pan-Tumor-) Therapieansätze basierend auf Kombinationen mit BNT327/PM8002 sowie den
How Cigna Remains at the Top of the Health Insurance Food Chain
The health insurance industry has received a lot of backlash over its managed care practices that bog down providers with pre-authorizations and rampant medical claim denials. The rise in medical
Top 3 Stocks Seeing a Spike in Call Option Volume
Volume is what drives the entire market, and that is a fact that often gets lost in the sea of indicators, patterns, and trend lines that dominate today’s concept of analysis. However, most
3 Stocks Helping to Bring AI to Healthcare
Artificial intelligence stocks are expected to continue showing strong growth in 2025. Much of the attention focuses on the opportunity that comes from the buildout of data centers. But a
Pfizer: 4 Reasons to Buy This Stock
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to climb over the $30 mark, something causes shares to slide right back down
Vertex im IDC MarketScape 2024 als Leader für weltweite SaaS- und Cloud-fähige Software zur Steuerautomatisierung für Großunternehmen, KMU´s und VAT ausgezeichnet
KING OF PRUSSIA, Pa., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) („Vertex“ oder das „Unternehmen“), ein globaler Anbieter von Steuertechnologielösungen, wurde in drei IDC
GRAIL: Biotech Stock Targeting $100B Cancer Market
GRAIL (NASDAQ: GRAL) is a small-cap biotechnology company that has gone on a very strong run over the last month and a half. Shares of the healthcare stock are up 58% since Oct. 24, as of the
2 Healthcare Stocks to Buy Ahead of the New Year
Healthcare stocks as a group have not performed on par with broader equities this year. However, that doesn't mean investors should avoid the sector altogether. Many healthcare companies appear to
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
Looking for great stocks to be had at a bargain? Even though broader equities have performed well this year, there are companies, particularly in sectors that haven't kept up with the rest of the
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026.
It now seems so long ago that Pfizer (NYSE: PFE) became the first company in the biopharmaceutical industry to generate over $100 billion in annual sales. The drugmaker achieved this milestone
The Best Turnaround Stock to Invest $1,000 in Right Now
Even very well-run companies will eventually fall upon hard times. That's the backstory you need to keep in mind when you examine Bristol Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE). Here's why
Is AbbVie Stock Too Cheap to Ignore at Today's Price?
AbbVie (NYSE: ABBV), a pharmaceutical leader, has faced some challenges over the past three years. The company is managing some patent cliffs and clinical setbacks that worried investors and dinged
Down 50%, Should You Buy the Dip on Pfizer?
Pfizer (NYSE: PFE) is deeply unloved today. There are a couple of reasons for this that are important, but the big story revolves around the company's drug portfolio. With three drugs facing patent
Vertex Stock: Why One Fund Lifted Its $94.3 Million Position Even as Shares Sank
On November 14, California-based Tensile Capital Management disclosed a buy of 160,559 shares of Vertex (NASDAQ:VERX) in the third quarter. Despite the expanded stake, the market value of the
Forget Medtronic, Buy This Healthcare Stock Instead
There are compelling reasons for some investors to consider investing in Medtronic (NYSE: MDT), depending on their goals and risk tolerance. It is a well-established healthcare leader that generates